SHILPA MEDICARE Financial Statement Analysis
|
||
|
The Revenues of SHILPA MEDICARE have increased by 9.66% YoY .
The Earnings Per Share (EPS) of SHILPA MEDICARE has increased by Positive YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SHILPA MEDICARE Last 5 Annual Financial Results
[BOM: 530549|NSE : SHILPAMED]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,152 Cr | ₹1,050 Cr | ₹1,146 Cr | ₹901 Cr | ₹908 Cr |
| Expenses | ₹916 Cr | ₹962 Cr | ₹948 Cr | ₹729 Cr | ₹693 Cr |
| Operating Profit (Excl OI) | ₹236 Cr | ₹88 Cr | ₹197 Cr | ₹172 Cr | ₹215 Cr |
| Other Income | ₹17 Cr | ₹31 Cr | ₹21 Cr | ₹40 Cr | ₹22 Cr |
| Interest | ₹92 Cr | ₹59 Cr | ₹41 Cr | ₹22 Cr | ₹4.56 Cr |
| Depreciation | ₹108 Cr | ₹95 Cr | ₹80 Cr | ₹54 Cr | ₹44 Cr |
| Profit Before Tax | ₹54 Cr | ₹-38 Cr | ₹102 Cr | ₹195 Cr | ₹188 Cr |
| Profit After Tax | ₹32 Cr | ₹-31 Cr | ₹61 Cr | ₹146 Cr | ₹155 Cr |
| Consolidated Net Profit | ₹32 Cr | ₹-32 Cr | ₹61 Cr | ₹148 Cr | ₹156 Cr |
| Earnings Per Share (Rs) | ₹3.67 | ₹-3.74 | ₹6.99 | ₹18.13 | ₹19.15 |
| PAT Margin (%) | 2.77 | -2.94 | 5.29 | 16.22 | 17.02 |
| ROE(%) | 1.78 | -1.71 | 3.67 | 10.41 | 12.23 |
| ROCE(%) | 5.49 | 0.80 | 5.94 | 10.73 | 12.38 |
| Total Debt/Equity(x) | 0.52 | 0.45 | 0.37 | 0.57 | 0.29 |
Key Financials |
||
| Market Cap | : | ₹ 6,159.4 Cr |
| Revenue (TTM) | : | ₹ 1,247.3 Cr |
| Net Profit(TTM) | : | ₹ 92.0 Cr |
| EPS (TTM) | : | ₹ 9.4 |
| P/E (TTM) | : | 67.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHILPA MEDICARE | -5% | 1% | 34.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
| DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
| CIPLA | -1.8% | 1% | 0.5% |
| TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
| DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
| MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
| ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
| LUPIN | -2.7% | 1% | 30.1% |
SHILPA MEDICARE Revenues
[BOM: 530549|NSE : SHILPAMED]
| Y-o-Y | 9.66 % |
| 5 Yr CAGR | 6.12 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,152 Cr | 9.66 | |
| Mar2023 | ₹1,050 Cr | -8.33 | |
| Mar2022 | ₹1,146 Cr | 27.12 | |
| Mar2021 | ₹901 Cr | -0.75 | |
| Mar2020 | ₹908 Cr | - | |
SHILPA MEDICARE Operating Profit
[BOM: 530549|NSE : SHILPAMED]
| Y-o-Y | 167.45 % |
| 5 Yr CAGR | 2.42 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹236 Cr | 167.45 | |
| Mar2023 | ₹88 Cr | -55.24 | |
| Mar2022 | ₹197 Cr | 14.85 | |
| Mar2021 | ₹172 Cr | -19.96 | |
| Mar2020 | ₹215 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 143.76 % |
| 5 Yr CAGR | -3.49 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 20.5% | 143.76 | |
| Mar2023 | 8.41% | -51.13 | |
| Mar2022 | 17.21% | -9.66 | |
| Mar2021 | 19.05% | -19.38 | |
| Mar2020 | 23.63% | - | |
SHILPA MEDICARE Profit After Tax
[BOM: 530549|NSE : SHILPAMED]
| Y-o-Y | Positive |
| 5 Yr CAGR | -32.78 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹32 Cr | Positive | |
| Mar2023 | ₹-32 Cr | Negative | |
| Mar2022 | ₹61 Cr | -58.95 | |
| Mar2021 | ₹148 Cr | -5.36 | |
| Mar2020 | ₹156 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | -36.48 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 2.77 % | Positive | |
| Mar2023 | -2.94 % | Negative | |
| Mar2022 | 5.29 % | -67.39 | |
| Mar2021 | 16.22 % | -4.70 | |
| Mar2020 | 17.02 % | - | |
SHILPA MEDICARE Earnings Per Share (EPS)
[BOM: 530549|NSE : SHILPAMED]
| Y-o-Y | Positive |
| 5 Yr CAGR | -33.84 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹3.67 | Positive | |
| Mar2023 | ₹-3.74 | Negative | |
| Mar2022 | ₹6.99 | -61.45 | |
| Mar2021 | ₹18 | -5.33 | |
| Mar2020 | ₹19 | - | |
SHILPA MEDICARE Return on Capital Employed (ROCE)
[BOM: 530549|NSE : SHILPAMED]
| Y-o-Y | 586.25 % |
| 5 Yr CAGR | -18.40 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 5.49% | 586.25 | |
| Mar2023 | 0.8% | -86.53 | |
| Mar2022 | 5.94% | -44.64 | |
| Mar2021 | 10.73% | -13.33 | |
| Mar2020 | 12.38% | - | |
SHILPA MEDICARE Share Price vs Sensex
| Current Share Price | : | ₹629.8 |
| Current MarketCap | : | ₹ 6,159.4 Cr |
| Updated EOD on | : | Apr 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | -5% |
1% |
34.4% |
| SENSEX | -2.9% |
3.1% |
1.8% |
SHILPA MEDICARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE MIDSMALLCAP | 1.4% | 9.3% | 8.2% |
| BSE ALLCAP | -0.8% | 4.8% | 5.8% |
| BSE SMALLCAP | -2% | 7.2% | 3.2% |
| BSE HEALTHCARE | -2.3% | 5.7% | 14.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MICROCAP 250 | -2.2% | 5.8% | 4.2% |
| NIFTY TOTAL MARKET | -2.8% | 4.6% | 1.6% |
You may also like the below Video Courses
FAQ about SHILPA MEDICARE Financials
How the annual revenues of SHILPA MEDICARE have changed ?
The Revenues of SHILPA MEDICARE have increased by 9.66% YoY .
How the Earnings per Share (EPS) of SHILPA MEDICARE have changed?
The Earnings Per Share (EPS) of SHILPA MEDICARE has increased by Positive YoY .
Check out Intrinsic Value of Peers of SHILPA MEDICARE
Compare Stock Analytics of Peers of SHILPA MEDICARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
